Selective serotonin-reuptake inhibitors in the treatment of premature ejaculation
- PMID: 15941821
- DOI: 10.1345/aph.1E069
Selective serotonin-reuptake inhibitors in the treatment of premature ejaculation
Abstract
Objective: To review the use of selective serotonin-reuptake inhibitors (SSRIs) in the treatment of premature ejaculation.
Data sources: Articles were retrieved through a MEDLINE search (1966-January 2004). Search terms used to identify articles included serotonin uptake inhibitors, premature ejaculation, rapid ejaculation, and sexual behavior, as well as the generic names of currently available SSRIs: fluoxetine, fluvoxamine, paroxetine, sertraline, citalopram, and escitalopram. The literature search was limited to articles published in the English language containing human subjects.
Study selection and data extraction: Articles obtained through the literature search were evaluated, and randomized controlled trials were included in this review. Information from noncontrolled trials or case reports was considered for inclusion if it contributed to the completeness of this review and if it was the highest level of evidence available.
Data synthesis: Premature ejaculation is a commonly reported sexual difficulty. Delayed ejaculation is a widely reported sexual adverse effect of SSRIs. In some men exhibiting premature ejaculation, the ability of the SSRIs to delay ejaculation has been therapeutic. Trials evaluating the ejaculation-delaying ability of SSRIs demonstrated that paroxetine, fluoxetine, sertraline, and citalopram produce a statistically significant increase in the ejaculation latency time compared with placebo.
Conclusions: Taking advantage of the ejaculation-delaying effects of SSRIs increases the treatment options available to prescribers and patients. Convenience and minimal adverse effect profile make these agents an alternative to previously used behavior modalities and older pharmacologic agents. Although some questions still surround the details of their use, SSRIs have the potential to improve the quality of life for men with premature ejaculation and their partners.
Similar articles
-
Selective serotonin reuptake inhibitors in the treatment of premature ejaculation.Chin Med J (Engl). 2007 Jun 5;120(11):1000-6. Chin Med J (Engl). 2007. PMID: 17624269 Review.
-
Utility of selective serotonin reuptake inhibitors in premature ejaculation.Curr Opin Investig Drugs. 2004 Jul;5(7):743-7. Curr Opin Investig Drugs. 2004. PMID: 15298071 Review.
-
Serotonin and premature ejaculation: from physiology to patient management.Eur Urol. 2006 Sep;50(3):454-66. doi: 10.1016/j.eururo.2006.05.055. Epub 2006 Jun 19. Eur Urol. 2006. PMID: 16844284 Review.
-
Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.J Clin Psychopharmacol. 1998 Aug;18(4):274-81. doi: 10.1097/00004714-199808000-00004. J Clin Psychopharmacol. 1998. PMID: 9690692 Clinical Trial.
-
The comparison of combination SSRI and PDE-5 inhibitor therapy to SSRI monotherapy in men with premature ejaculation.Ann Pharmacother. 2011 Jul;45(7-8):1000-4. doi: 10.1345/aph.1Q008. Epub 2011 Jul 20. Ann Pharmacother. 2011. PMID: 21775693 Review.
Cited by
-
The impact of treatment with selective serotonin reuptake inhibitors on primate cardiovascular disease, behavior, and neuroanatomy.Neurosci Biobehav Rev. 2017 Mar;74(Pt B):433-443. doi: 10.1016/j.neubiorev.2016.08.037. Epub 2016 Aug 30. Neurosci Biobehav Rev. 2017. PMID: 27590831 Free PMC article. Review.
-
Long term sertraline effects on neural structures in depressed and nondepressed adult female nonhuman primates.Neuropharmacology. 2015 Dec;99:369-78. doi: 10.1016/j.neuropharm.2015.06.011. Epub 2015 Jun 24. Neuropharmacology. 2015. PMID: 26116816 Free PMC article.
-
Effects of long-term sertraline treatment and depression on coronary artery atherosclerosis in premenopausal female primates.Psychosom Med. 2015 Apr;77(3):267-78. doi: 10.1097/PSY.0000000000000163. Psychosom Med. 2015. PMID: 25829239 Free PMC article.
-
Preclinical evidence supporting the clinical development of central pattern generator-modulating therapies for chronic spinal cord-injured patients.Front Hum Neurosci. 2014 May 30;8:272. doi: 10.3389/fnhum.2014.00272. eCollection 2014. Front Hum Neurosci. 2014. PMID: 24910602 Free PMC article. Review.
-
Serotonin depletion counteracts sex differences in anxiety-related behaviour in rat.Psychopharmacology (Berl). 2013 Nov;230(1):29-35. doi: 10.1007/s00213-013-3133-6. Epub 2013 May 17. Psychopharmacology (Berl). 2013. PMID: 23681161
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical